Artiva Biotherapeutics Is A Clinical Stage Biotechnology Company Based In San Diegocaliforniafounded In 2019It Specializes In Developing Allogeneic Natural Killernkcell Based Therapies Aimed At Treating Autoimmune Diseases And Cancersthe Company Holds Exclusive Global Rights To Nk Cell Manufacturing Technology From Gc Cellwhich Supports Its Innovative Therapeutic Approaches Artiva Focuses On Off The Shelfnon Genetically Modified Nk Cell Therapies That Enhance Antibody Dependent Cellular Cytotoxicityadcc Its Lead Productallonka Is A Cryopreserved Nk Cell Therapy Candidate Currently In Clinical Trials For Systemic Lupus Erythematosus And Other Autoimmune Conditionsthe Company Is Also Developing Car Nk Candidates Targeting Hematologic Malignancies And Solid Tumorswith A Commitment To Improving Tumor Targeting Precision Artiva Is Expanding Its Operations With A New 52 000 Square Foot Facility That Will Support Its Researchdevelopmentand Manufacturing Effortsthe Company Collaborates With Academic Institutions And Biopharmaceutical Companies To Advance Its Clinical Trials And Combination Therapiesemphasizing Accessibility And Safety In Its Product Offerings
